The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort

INTRODUCTION: Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide news and media attention in the treatment of patients with coronavirus disease 2019 (COVID-19). This drug was used on the basis of its antimicrobial and antiviral properties despite lack of definite evidence of cl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Dis Ther
Hlavní autoři: Abdulrahman, Abdulkarim, AlSayed, Islam, AlMadhi, Marwa, AlArayed, Jumana, Mohammed, Sara Jaafar, Sharif, Aesha Khalid, Alansari, Khadija, AlAwadhi, Abdulla Ismael, AlQahtani, Manaf
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2021
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7822757/
https://ncbi.nlm.nih.gov/pubmed/33484407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-021-00397-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky